SonyaLynnHeathMD
Infectious Disease • Birmingham, ALAssistant Professor, Medicine, University of Alabama School of Medicine
Dr. Heath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-933-4497
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 2003 - 2006- University of Alabama Medical CenterResidency, Internal Medicine, 2000 - 2003
Virginia Commonwealth University School of MedicineClass of 2000
Certifications & Licensure
AL State Medical License 2001 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection Start of enrollment: 2008 Sep 01
- A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART Start of enrollment: 2010 Jun 01
- Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection Start of enrollment: 2014 Apr 28
- Join now to see all
Publications & Presentations
PubMed
- 50 citationsHeightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruptionMarcos V. P. Gondim, Scott Sherrill-Mix, Frederic Bibollet-Ruche, Ronnie M. Russell, Stephanie Trimboli
Science Translational Medicine. 2021-01-13 - 915 citationsThe major genetic determinants of HIV-1 control affect HLA class I peptide presentationFlorencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi
Science. 2010-12-10 - 172 citationsInitial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedHua-Xin Liao, Xi Chen, Supriya Munshaw, Ruijun Zhang, Dawn J. Marshall
The Journal of Experimental Medicine. 2011-10-24
Journal Articles
- Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution During the Acute Phase of InfectionFeng Gao, Sonya L Heath, mBio
Press Mentions
UAB Conducting Clinical Trials of COVID-19 Drugs, Therapies, Including Two Given to the PresidentOctober 7th, 2020- Alabama Hospitals Start Widespread Use of Plasma Treatments for CoronavirusSeptember 22nd, 2020
- University of Alabama Birmingham Launches Clinical Trial to Investigate if Tranexamic Acid Can Reduce COVID-19 SeveritySeptember 4th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
